asthma
Global Asthma Market to Hit $18 Billion by 2021
August 21 by Pharma IQ NewsAnticipation surrounds emergence of a new wave of biologic therapies The lucrative market for asthma drugs is set to hit $18 billion by 2021, according to new research from pharmaceutical analyst...
Treating Asthma with Monoclonal Antibody Based Drugs: Past Experience and Future Prospects
September 22 by Pharmaceuticals & Biotechnology EditorAsthma Insights with Matthew Catley, UCB
April 29 by Matthew CatleyMatthew Catley, Head of Respiratory Pharmacology, UCB, provides some insights into asthma and COPD. Please give some background about your company. What is your role, and what does it entail? U...